- OP Labs formerly Oxford Peptides
- Batch HPLC tested at ≥ 99% purity
- Storage: –20 °C long term; 2–8 °C short term
- Sold for research purposes only
CJC-1295 with DAC
Synonyms / Designations: CJC-1295-DAC, DAC:GRF
CAS Number: 446262-90-4
Molecular Formula: C165H269N47O46
Molecular Weight: 3647.2 g/mol
Peptide Classification: Synthetic growth hormone–releasing hormone (GHRH 1–29) analogue conjugated with Drug Affinity Complex (DAC)
Purity: ≥ 99% (HPLC, typical)
Appearance: White to off-white lyophilised powder
Pack Size: 2 mg (total)
Storage: Desiccated, protected from light, stored at –20 °C
Solubility: Soluble in sterile water and buffered aqueous solutions
Description & Mechanism
CJC-1295 with DAC is a synthetic analogue of growth hormone–releasing hormone (GHRH 1–29) that has been chemically modified through conjugation with a Drug Affinity Complex (DAC). The DAC moiety consists of a reactive linker designed to form a covalent association with circulating serum albumin, resulting in prolonged systemic persistence of the peptide in experimental systems. This bioconjugation alters pharmacokinetic behaviour while preserving the core peptide sequence responsible for receptor interaction.
In biochemical and cellular research models, CJC-1295 with DAC interacts with the GHRH receptor expressed on pituitary-derived cells, initiating intracellular signalling cascades associated with growth hormone secretion. Preclinical research studies have examined receptor activation dynamics, signalling duration, and downstream endocrine pathway engagement under extended exposure conditions. Observed molecular and physiological responses are dependent on experimental design, exposure protocol, and model system, and are used to investigate prolonged GHRH receptor signalling rather than defined biological or physiological outcomes.
Applications in Research
- As a molecular probe to study GHRH receptor binding and activation dynamics.
- Investigation of growth hormone axis signalling and endocrine feedback mechanisms.
- In cellular assays examining downstream transcriptional and signalling responses.
- In preclinical research models assessing extended-duration peptide–receptor interaction resulting from albumin binding
Specifications Summary
| Parameter | Typical Value / Range |
|---|---|
| Purity (HPLC) | ≥ 99% |
| Appearance | White to off-white lyophilised powder |
| Molecular Weight | ~3,647.2 g/mol |
| Peptide Type | Synthetic GHRH analogue with DAC |
| Solubility | Water, buffered aqueous solutions |
| Storage | –20 °C, desiccated, dark |
| Pack Size | 2 mg |
Precautions & Notes
- Experimental behaviour of CJC-1295 with DAC is influenced by albumin binding and concentration.
- Buffer composition, pH, and ionic strength may affect peptide stability and assay performance.
- Intended strictly for laboratory research use; not for human or veterinary application.
Keywords: CJC-1295 with DAC, DAC:GRF, GHRH Analogue








